Cure My Disease

Don't miss your cure!

 Log in / Sign up

Online course eases death anxiety in small trial

NCT ID NCT06801132

Symptom relief Sponsor: Peking University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a self-guided online program designed to help people manage their fear of death. 47 adults with high death anxiety were split into two groups: one received the 2-hour online intervention, the other was placed on a waiting list. Researchers measured changes in death anxiety, beliefs, and behaviors right after the program and again at 1 and 2 weeks later.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

47 people

The number who actually took part.

Started

Feb 2025

Finished

Apr 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18-65 years of age * Normal literacy skills and ability to use a smartphone proficiently * Higher death anxiety that is above the cutoff of our measurement * Voluntarily participate in this intervention and be able to provide informed consent. Exclusion Criteria: * Severe depressive state or risk of suicidal self-injury, i.e., the total score of Patient Health Questionnaire 9-item ≥19 or the score of 9th item ≥2 * Diagnosed within 6 months with schizophrenia, depression, bipolar disorder, and other psychiatric disorders * Have received any intervention for death anxiety or CBT intervention on any topic within the past 6 months.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Death anxiety are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Necrophobia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Death anxiety

Contacts and locations

Locations

  • Peking University

    Beijing, Beijing Municipality, 100871, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.